Pseudopeptide CCK-4 analogues incorporating the Ψ[CH(CN)NH] peptide bond surrogate

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 7, 1997, Pages 855-860

  Herrero, Susana ^a   Suárez Gea, M Luisa ^a   González Muñiz, Rosario ^a   García López, M Teresa ^a   Herranz, Rosario ^a   Ballaz, Santiago ^b   Barber, Ana ^b   Fortuño, Ana ^b   Del Río, Joaquín ^b  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ DERIVATIVE; PD 135158; PSEUDOPEPTIDE; TETRAGASTRIN DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CHIRALITY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GUINEA PIG; ILEUM; IN VITRO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PANCREAS; SMOOTH MUSCLE CONTRACTION; STRUCTURE ACTIVITY RELATION;

EID: 0343144844     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00107-8     Document Type: Article

References (22)

1. (a) Spatola, A. F. In Chemistry and Biochemistry of Amino Acids, Peptides and Proteins; Weinstein, B., Ed.; Marcel Dekker: New York, 1983; Vol. 7 pp 267-357.
2. (b) Bladon, C. M. In Amino Acids, Peptides and Proteins; Davies, J. S., Ed.; Royal Society of Chemistry: Cambridge, 1994; Vol. 25, pp 154-171.
3. Herranz, R.; Suárez-Gea, M. L.; Vinuesa, S.; García-López, M. T.; Martínez, A. Tetrahedron Lett. 1991, 32, 7579-7582.
4. Herranz, R.; Suárez-Gea, M. L.; Vinuesa, S.; García-López, M. T. J. Org. Chem. 1993, 58, 5186-5191.
5. González-Muñiz, R.; García-López, M. T.; Gómez-Monterrey, I.; Herranz, R.; Jimeno, M. L.; Suárez-Gea, M. L.; Johansen, N.L.; Madsen, K.; Thøgersen, H.; Suzdak, P. J. Med. Chem. 1995, 38, 1015-1021.
6. Martinez, J. In Comprehensive Medicinal Chemistry, Hansch, C. Ed.; Pergamon Press: Oxford, 1990; Vol. 3, pp 929-959.
7. Receptor and Ion Channel Nomenclature Supplement. 7 Ed Trends Pharmacol. Sci. 1996, 24-26, and references cited therein.
8. Horwell, D. C. In Topics in Medicinal Chemistry, Leeming, P. R. Ed.; Royal Society of Chemistry: Cambridge, 1988; pp 62-72.
9. Etzkorn, F. A.; Guo, T.; Lipton, M. A.; Goldberg, S. D.; Bartlett, P. A. J. Am. Chem. Soc. 1994, 116, 10412-10425.
10. Barany, G.; Merrifield, R. B. In The Peptides. Analysis, Synthesis, Biology, Gross, E.; Meienhofer, J. Eds.; Academic Press, Inc.: New York, 1980, Vol. 2, pp 217-222.
11. 3CN.
12. 3CN.
13. (a) Bongers, J.; Heimer, E. P.; Lambros, T.; Pan, Y. E.; Campbell, R. M.; Felix, A. M. Int. J. Peptide Protein Res. 1992, 39, 364-374.
14. (b) Kates, S. A.; Albericio, F. Lett. Peptide Sci. 1994, 1, 213-220.
15. Baba, T.; Sugiyama, H.; Seto, S. Chem. Pharm. Bull. 1973, 21, 207-209.
16. Daugé, V.; Bohme, G. A.; Crawley, J. N.; Duriex, C.; Stutzmann, J. M.; Feger, J.; Blanchard, J. C.; Roques, B. P. Synapse, 1990, 6, 73-80.
17. Hughes, J.; Boden, P.; Costall, B.; Domeney, A.; Kelly, E.; Horwell, D. C.; Hunter, J. C.; Pinnock, R. D.; Woodruff, G. N. Proc. Natl. Acad. Sci. USA 1990, 87, 6728-6732.
18. Holladay, M. W.; Lin, C. W.; May, C. S.; Garvey, D. S.; Witte, D. G.; Miller, T. R.; Wolfram, C. A. W.; Nazdan, A. M. J. Med. Chem. 1991, 34, 455-457.
19. Lucaites, V. L.; Mendelsohn, L. G.; Mason, N. R.; Cohen, M.L. J. Pharmacol. Exp. Ther. 1991, 256, 695-703.
20. Weng, J. H.; Blommaert, A. G. S.; Moizo, L.; Bado, A.; Ducos, B.; Böhme, A.; Garbay, C.; Roques, B.P. Bioorg. Med. Chem. 1996, 4, 563-573.
21. (a) Schmassmann, A.; Garner, A.; Flogerzi, B.; Hasan, M.Y.; Varga, L.; Halter, F. Gut 1994, 35, 270-274.
22. (b) Ding, X. Q.; Chen, D.; Håkanson, R. Pharmacol. Toxicol. 1995, 76, 83.